In another animal model, the treatment of obstructive-sleep-apnea-induced hypertension in rats with the probiotic Lactobacillus rhamnosus GG strain provided a lower level of TMAO and CD4+ T cell induced-type I inflammation, leading to a reduction in hypertension [97]. This evidence concerns the gene CD4 and hypertensive disorder.